ライフサイエンスコーパス: number of patient

1 rly prosthetic degeneration in a significant number of patients.

2 rden below the detection limit for a greater number of patients.

3 nd effectiveness of pegbelfermin in a larger number of patients.

4 osis, cirrhosis, and cancer in a significant number of patients.

5 one of these alone would miss a significant number of patients.

6 ated prematurely before enrolling the target number of patients.

7 nefits of limited resources for the greatest number of patients.

8 s a p value less than 0.10, due to the small number of patients.

9 tracers for imaging applications in a larger number of patients.

10 AT & epoxide) and cloning was attempted in a number of patients.

11 for the administration of vaccines to large numbers of patients.

12 astic leukemia (ALL), often comprising small numbers of patients.

13 idely explored, but often only benefit small numbers of patients.

14 technologies with potential to benefit large numbers of patients.

15 e following original research, cohort study, number of patients 10 or more, and reported change in ma

16 Similar numbers of patients achieved clinical stability in each

17 The number of patients achieving an objective response was t

18 coding improved significantly along with the number of patients achieving BP targets in the intervent

19 effectiveness of dupilumab was expressed as number of patients achieving EASI-50 (Eczema Area and Se

20 numbers of patients coded for CKD, mean BP, numbers of patients achieving National Institute for Hea

21 of whole genome sequencing data in the large number of patients affected by congenital heart defects.

22 ear study period (2012-2014), we tracked the number of patients affected by MDRPa (colonized and/or i

23 that uses both variation in performance and number of patients affected by the QM to set priorities

24 Number of patients, age, gender, surgeon, and osteotomy

25 We used UK CF Registry data to project the number of patients aged 16-17 and 18 and older up to 203

26 estimated glomerular filtration rate and the number of patients alive without dialysis) 1 y after tra

27 Despite the limited number of patients, an exploratory ID(50) of 2 mg/kg and

28 al outcome evaluation remains limited by the number of patients analyzed, in particular, for recent-g

29 son of both therapies remains limited by the number of patients analyzed.

30 ases of active myopic CNV; however, a larger number of patients and a longer follow-up period are nee

31 nown as inhibitors, develop in a significant number of patients and actively block FVIII activity, ma

32 tterns of dissemination owing to the limited number of patients and available metastases.

33 4 (CTLA-4) for cancer immunotherapy, a large number of patients and cancer types remain unresponsive.

34 t could not be analyzed because of the small number of patients and diversity of outcomes reported.

35 roduced leaf beetle Ophraella communa on the number of patients and healthcare costs.

36 Acknowledging the limitations of the small number of patients and of the uncontrolled nature of the

37 Meta-analysis limitations were the small number of patients and the high risk of bias.

38 s was mostly explained by differences in the number of patients and visits for family physicians but

39 s was mostly explained by differences in the number of patients and visits for family physicians, but

40 batch effects and integrate data from large numbers of patients and conditions across batches, to co

41 ch articles, we also extracted study design, number of patients, and primary outcomes.

42 s, and as the population ages, an increasing number of patients are anticipated to present for care.

43 approval in Western medicine, an increasing number of patients are being treated on an expanded-acce

44 A significant number of patients are hospitalized for the management o

45 An increasing number of patients are requiring multiple retransplants.

46 Thus, a substantial number of patients are spared the adverse effects of sys

47 The number of patients assigned to chest CT categories typic

48 g those in the C-terminal domain and a large number of patient-associated missense mutations in the R

49 , and 4 [2-6] in placebo group), nor did the number of patients at day 90 with an NIHSS score of up t

50 ngle-agent cohort late in phase 2 in a small number of patients at the maximum tolerated dose identif

51 demonstrated feasibility of screening large numbers of patients at numerous accruing sites in a comp

52 emic have reported a substantial drop in the number of patients attending the emergency department wi

53 However, the number of patients awaiting solid organ transplantation

54 culatory support, are available to a limited number of patients because of the scarcity of donors, ex

55 0352), and those from ICUs with an increased number of patient beds (beta 5.729; p <= 0.0001).

56 Aging of the population further adds to the number of patients being treated for cancer, especially

57 with HO stems improved ROM for ADL in a low number of patients below 10% (p > 0.03).

58 The risk for PME is low and the number of patients benefiting from treatment is small.

59 million [13.2 million to 70.9 million]), the number of patients blind because of cataract is anticipa

60 control of A. artemisiifolia will reduce the number of patients by approximately 2.3 million and the

61 A small but significant number of patients carry causal variants in LRRK2, SNCA,

62 ained reasonably complete data for a limited number of patient characteristics, namely age, sex, and

63 In recent years, the number of patients choosing to have direct-to-consumer (

64 Secondary outcomes included numbers of patients coded for CKD, mean BP, numbers of p

65 not differ by disease category, sex, age, or number of patient comorbidities (P=0.69, P=1.00, P=0.46,

66 y, there were significant differences in the number of patient contacts and self-contacts that HCWs m

67 The number of patient conversions to hepatectomy was seven f

68 nhibitors had potent activity across a large number of patient-derived models of PDAC underscoring th

69 eated with tamoxifen; however, a significant number of patients develop tamoxifen-resistant disease.

70 The number of patients diagnosed with chronic bile duct dise

71 of mammographic screening will increase the number of patients diagnosed with DCIS, making a precise

72 Indeed, significant numbers of patients diagnosed with MCI do not 'convert'

73 At the same time, there are also increasing numbers of patients diagnosed with one of the inherited

74 tric hospitals to provide treatment to large numbers of patients during a large-scale disaster remain

75 re sensitive way to detect efficacy in small numbers of patients during early drug development.

76 A considerable number of patients elected to control the post-surgical

77 The number of patients eligible for each indicator ranged fr

78 The number of patients eligible for surgery decreased by 62%

79 ically meaningful benefits to an appreciable number of patients, emerging evidence indicates that the

80 Given the limited number of patients enrolled in the available studies, la

81 The number of patients evaluated for nivolumab discontinuati

82 For regions with bed shortfalls (where the number of patients exceeded bed capacity), transfers to

83 A significantly greater number of patients exhibited durable MI block in the VOM

84 In the ablation arm, a significantly higher number of patients experienced an improvement in their L

85 In addition to doubling the number of patients for many NDD risk genes, we present p

86 The number of patients for whom adverse events were reported

87 which are now being prescribed to increasing numbers of patients for a wide variety of indications.

88 inical heterogeneity associated with the low number of patients has led to a delay in the development

89 ) have conflicting results, comprise a small number of patients, have short follow-up periods, and la

90 An increasing number of patients having cancer surgery rely on PAC fac

91 The limited number of patients having directives is worrisome and st

92 The number of patients hospitalized with worsening HF or dia

93 EHR pull alone but was limited by the small number of patients identified.

94 HIV disease progression by analyzing a large number of patients in 3 cohorts with different HIV disea

95 The number of patients in each category was: 1098 (>=2-<=12

96 limitation; however, it is equivalent to the number of patients in phase II clinical trials.

97 n dispensed for each medicine class, and the number of patients in receipt of a prescription for at l

98 A substantial number of patients in the ARISTOTLE trial took NSAIDs.

99 suggestive of IBD considerably decreased the number of patients in the group in whom challenges in cl

100 However, a higher number of patients in the porcine group had additional g

101 The number of patients in the postanesthesia care unit with

102 Several smaller level III case series (total number of patients in these 13 studies was 163) revealed

103 ndard patching standard treatment (the total number of patients in these 2 studies was 147).

104 rger and more rigorously designed (the total number of patients in these 5 studies was 813).

105 The total number of patients included was 10,206 (18,689 eyes).

106 Over the past decade, the number of patients infected with Mycobacterium tuberculo

107 ntly, multiple medicines prescribed to large numbers of patients influence the Treg compartment; howe

108 remental outcomes were most sensitive to the number of patients initiating and completing treatment.

109 the study, we suggest that a possibly large number of patients labeled as IBS-D or IBS-M may actuall

110 interpretation of results, particularly when number of patients lost to follow-up exceeds FI.

111 The FI and FI minus number of patients lost to follow-up of RCTs supporting

112 .0 (95% CI, 5.0-9.0) and the median FI minus number of patients lost to follow-up was 1.0 (95% CI, 0.

113 In 37 trials (30.1%), number of patients lost to follow-up was higher than the

114 The number of patients lost to follow-up was observed at dif

115 revascularization using the FI and FI minus number of patients lost to follow-up.

116 of trials reveal a FI that is lower than the number of patients lost to follow-up.

117 Although the number of patients meeting this criteria is high, 53.5%

118 Based on data from a small number of patients (n = 6), an intensified 16-week regim

119 operative fetoscopy; and (2) To estimate the number of patients needed to study the predictive value

120 ver the median follow-up of 18.2 months, the number of patients needed to treat with dapagliflozin to

121 s, preserve treatment effect, and reduce the number of patients needed.

122 The primary end point was the number of patients no longer requiring surgery at Week 2

123 nted defibrillators has grown, an increasing number of patients nonischemic cardiomyopathies are requ

124 The substantial number of patients not entering this trial randomisation

125 vascular disease (CVD) were limited by small numbers of patients or a narrow range of endpoints.

126 at remissions will be brief in a substantial number of patients owing to poor CAR T cell persistence

127 The number of patients per clinic day, the cost per visit, a

128 secondary analysis that was adjusted for the number of patients per resident physician as a potential

129 The median number of patients per study was 185 (interquartile rang

130 A growing number of patients previously treated with older techniq

131 ximize the diagnostic yield and increase the number of patients receiving personalized care and couns

132 BackgroundWith growing numbers of patients receiving deep brain stimulation (DB

133 egory 3 classification; however, the overall number of patients recommended for short-interval follow

134 ns in the United States suggest limiting the number of patient records displayed in an electronic hea

135 different data domains (data diversity), the number of patient records in the training data set (data

136 Number of patients recruited, level of detected DR, chan

137 rapies that block ER activity, a significant number of patients relapse.

138 However, considerable numbers of patients relapse after the treatment, partial

139 With an increasing number of patients relying on blood thinners to treat me

140 There was no difference in the number of patients requesting a change in resuscitation

141 n in power, with a 67% mean reduction in the number of patients required in a drug trial for severe e

142 ns and CART constructs enter the clinic, the number of patients requiring ICU admission will rapidly

143 rus infection have reduced mortality and the number of patients requiring liver transplantation, but

144 onfidence in a range of glaucoma procedures, number of patients requiring referral to specialist cent

145 The Fragility Index, which represents the number of patients responsible for a statistically signi

146 f cancer genomics continually matures as the number of patient samples sequenced increases.

147 ing volatility indices measured from a small number of patient samples, we accurately predict the pop

148 The primary outcome was the number of patients screened, eligible, recruited, and ra

149 The average number of patients seen monthly was lowest for hepatolog

150 This included the number of patients seen within each clinic, operational

151 mentary regression models were generated for number of patients seen, number of services performed pe

152 There was no difference in number of patients showing improvement of >/=1 Canadian

153 06 approvals, respectively, while the median number of patients studied did not change significantly

154 ociated with improved survival, although the number of patients studied was small and heterogeneity w

155 A large number of patients suffer with cognitive disabilities an

156 The number of patients suffering from allergic asthma and rh

157 Despite the large number of patients suffering from food allergies, up unt

158 cost) effective treatment for the increasing number of patients suffering from kidney disease.

159 The number of patients suffering from solid organ disease co

160 Despite the rapidly increasing number of patients suffering from type 2 diabetes, Alzhe

161 ry and electrolyte imbalances in an alarming number of patients taking PPIs.

162 A web-based survey that queried the number of patients that a hepatologist cares for, RVU pr

163 guide antibiotic treatment and increase the number of patients that complete therapy.

164 ures, our method substantially increases the number of patients that may be considered for treatments

165 The total number of patients that received MMF was 799.

166 hat the patients generate rather than on the number of patients the nurse has to take care of in the

167 Given the small number of patients, this study was unable to unequivocal

168 re was still DME resolution in an increasing number of patients through week 24.

169 vercome these caveats allowing for a greater number of patients to benefit from advancements in genet

170 among stage groups, upstaging a significant number of patients to stage IV.

171 esent, VCA is an emerging field with a small number of patients transplanted.

172 usually after a long delay, in a significant number of patients treated by LT for liver complications

173 The number of patients treated for aortic valve disease in t

174 ns or losses of patients (difference between number of patients treated in a centre and number expect

175 to-needle decreased by 1.8 minutes (P=0.02), number of patients treated with alteplase was an additio

176 but training them requires data from a large number of patients treated with each drug, limiting thei

177 dy to quantify the reduction in sample size, number of patients treated with the standard of care, an

178 ons of this study include a relatively small number of patients, treatment duration up to only 56 day

179 A substantial number of patients undergoing LT are not immune to vacci

180 100% SVR rate in era 3 and a decrease in the number of patients undergoing reLT for recurrent hepatit

181 The number of patients undergoing robotic surgery was 317 (5

182 Importantly, the number of patients undergoing unnecessary SN biopsy woul

183 ome recognition and smaller decreases in the number of patients' visits to federally qualified health

184 The number of patients waiting to receive a kidney transplan

185 At 3, 6, and 12 months after treatment, the number of patients was 40, 31, and 31, respectively, and

186 The highest number of patients was in the age group of 51-60 years (

187 Although it is possible that a small number of patients was not registered into the program b

188 In the study, the highest number of patients were found to have tongue malignancy

189 Similar outcomes in smaller numbers of patients were observed with apixaban (n = 12)

190 The primary objective was to compare the number of patients who achieved a pathological complete

191 device treatment to potentially increase the number of patients who can be treated despite long trans

192 The number of patients who developed bowel obstruction withi

193 We evaluated the number of patients who developed hepatitis and examined

194 The number of patients who discontinued the trial regimen wa

195 eart failure management is compounded by the number of patients who experience adverse downstream eff

196 adjusted incident rate ratios [IRRs]) of the number of patients who had a prescription dispensed for

197 The primary outcome was the number of patients who had complete remission at any tim

198 (3.8) versus 6.8 days (3.2; p=0.84), and the number of patients who had unscheduled hospital admissio

199 FI is the minimum number of patients who must be moved from the nonevent g

200 Data on the number of patients who received second-line anticancer t

201 The authors have shown that a substantial number of patients who recovered sufficiently to allow e

202 The number of patients who reported adverse events was simil

203 Although the overall number of patients who reported IPV decreased during the

204 ily members did not significantly reduce the number of patients who reported significant PTSD symptom

205 l inclusion criteria, reducing by 20-25% the number of patients who show no progression.

206 The number of patients who stopped treatment because of adve

207 A significant number of patients who survive CO poisoning suffer from

208 Total number of patients who underwent LVMR was 848 and 99(12%

209 A difference between groups was noted in the number of patients who underwent secondary therapeutic p

210 The number of patients who underwent stenting ranged from 10

211 estimating neurological prognoses in a large number of patients who were initially comatose, in whom

212 d only in the CTP group because of the small numbers of patients who had perfusion MRI, was not assoc

213 potentially serving needs to a considerable number of patients whose dysfunctional vascular cells pr

214 fragility index (FI), defined as the minimum number of patients whose status would need to switch fro

215 d 1 year (0.3-1.6) in the control group, the number of patients with a 90% pathological response or h

216 51.3 mL/min/1.73 m(2)) and observed that the number of patients with a CKD stage G1, G2, G3a, G3b, G4

217 noramic 344 degrees -view revealed a greater number of patients with a relevant lesion (56.1% vs. 39.

218 brinolysis) can be detected in a significant number of patients with acute coronary syndrome (ACS) us

219 The number of patients with adult congenital heart disease (

220 afety-net hospitals treat a disproportionate number of patients with advanced appendicitis while fall

221 ) are complex and poorly understood, yet the number of patients with AF and HF continues to increase

222 tinues to grow with increasing lifespan, the number of patients with AMD will increase, and discussio

223 The number of patients with an ammonia level greater than 15

224 stressing problem that affects a substantial number of patients with and survivors of cancer; however

225 The number of patients with any serious adverse event did no

226 The primary outcome was the number of patients with at least one somatic serious adv

227 ions are expanding, leading to an increasing number of patients with bicuspid aortic stenosis undergo

228 Despite the number of patients with breast implants followed by Unit

229 However, the increasingly growing number of patients with breast implants has led to the i

230 ation' of therapies designed to increase the number of patients with cancer who are able to benefit f

231 The ever-increasing number of patients with complex, life-threatening diseas

232 Background A high number of patients with coronavirus disease 2019 (COVID-

233 As an increasing number of patients with COVID-19 are treated with these

234 t- and worst-case scenarios of surges in the number of patients with COVID-19, the needed total capac

235 n preparation for the expected surges in the number of patients with COVID-19.

236 The number of patients with CPC 1-2 at 90 days was 56 of 337

237 The number of patients with culture reversion was lower in t

238 A substantial number of patients with early diagnosis reaches adulthoo

239 outcome-opioid oversupply-was defined as the number of patients with either filled but unused opioid

240 The worldwide increase in the number of patients with end-stage renal disease leads to

241 ductions in ESRD mortality will increase the number of patients with ESRD by 29%-68% during the same

242 In conclusion, we demonstrate a relevant number of patients with FDG-PET false-negative MM and a

243 The number of patients with fibrosis stages 0, 1, 2, 3, and

244 The expected number of patients with hemophilia worldwide is 1 125 00

245 To determine whether a significant number of patients with hyperparathyroidism remain undia

246 he basis of research that includes a limited number of patients with ICH.

247 Despite these advances, a substantial number of patients with inflammatory arthritis remain re

248 er acute myocardial infarction (MI), a large number of patients with MI develop chronic heart failure

249 The number of patients with mild, general, severe, and criti

250 t no significant difference was found in the number of patients with mild/moderate cognitive impairme

251 ose To determine the association between the number of patients with multiple myeloma (MM) treated an

252 The number of patients with myocardial infarction and severe

253 and effectiveness of resmetirom in a larger number of patients with NASH with the possibility of doc

254 The number of patients with NETs and carcinoid syndrome incr

255 e malignancy index may be able to reduce the number of patients with nodular thyroid disease undergoi

256 to be limited knowledge because of the small number of patients with NSF.

257 olerability of asfotase alfa, defined as the number of patients with one or more treatment-emergent a

258 y in renal cell carcinoma, and increased the number of patients with pancreatic cancer who can underg

259 of case selection as reflected by increasing number of patients with pancreatic cancer, vascular rese

260 An increasing number of patients with pancreatic ductal adenocarcinoma

261 The number of patients with persistent asthma in the nationa

262 -DOTATATE treatment was divided by the total number of patients with preexisting peritoneal or mesent

263 f the best therapeutic choices for a growing number of patients with primary and metastatic liver can

264 Because of the low number of patients with reduced PS, the efficacy of this

265 The number of patients with reported bleeding decreased from

266 The number of patients with seronegative CRION and RION has

267 loped to provide treatment for a substantial number of patients with severe symptomatic mitral regurg

268 would permit transplantation to the highest number of patients with similar outcomes in recipients o

269 the primary pathomechanism of a significant number of patients with sporadic CH.

270 The number of patients with successful first-attempt intubat

271 The number of patients with symptomatic bleeding and brain b

272 For example, only a small number of patients with thyroid-stimulating hormone valu

273 t-acting antivirals (DAAs), due to the small number of patients with treatment failure in approval st

274 India has the highest number of patients with tuberculosis and multidrug-resis

275 highly dependent on weekday/weekend pattern, number of patients with various abnormal complete blood

276 The number of patients with venous thromboembolic events was

277 se inherited thrombophilias in a substantial number of patients with venous thromboembolism (VTE), th

278 ajor limitations we encountered were the low number of patients with whole-genome, unbiased analysis

279 tancy are the main reasons for an increasing number of patients with wound problems.

280 The numbers of patients with 0, 1, 2, or 3 factors (i.e., an

281 re was a substantial reduction in the weekly numbers of patients with acute coronary syndrome who wer

282 The numbers of patients with adverse events (79 [54%] in the

283 The numbers of patients with CH(4) >= 1 ppm (detectable) and

284 ithout patient navigation, in increasing the numbers of patients with cirrhosis undergoing surveillan

285 With surging numbers of patients with coronavirus disease 2019 (COVID

286 ilable for clinical evaluation; however, the numbers of patients with FL and the resources to conduct

287 (DPP-4) inhibitors but have included limited numbers of patients with high CV risk and chronic kidney

288 ers, physicians are challenged by increasing numbers of patients with intermittent or periodic fevers

289 pre-treatment loss to follow-up) between the numbers of patients with laboratory-confirmed RR-TB and

290 ure provides a mechanistic basis for the low numbers of patients with mutations in FANCB, FANCL and F

291 ransplantation (alloHCT) benefits increasing numbers of patients with otherwise lethal diseases.

292 d or best-corrected visual acuity, or in the numbers of patients with postoperative graft failure, gr

293 4 years after completion, resulting in large numbers of patients with rare diseases exposed to interv

294 Previous reports have included small numbers of patients with relatively short follow-up, pre

295 We estimated minimum and maximum numbers of patients with the outcome in each study group

296 exclusion criteria, they provide the largest numbers of patients within TCGA.

297 valence to prevalence at birth, and expected number of patients worldwide based on prevalence in high

298 the elderly and, therefore, affect a growing number of patients worldwide.

299 splantation (LTx) has been reported in small numbers of patients worldwide.

300 l would be challenging in design and a large number of patients would need to be included.